BOSTON, Oct 15 (Reuters) - Shares of Genzyme Corp rose as much as 7 percent on Monday amid speculation the biotechnology company could be a takeover target after rival Biogen Idec Inc put itself up ...
BOSTON, July 31 (Reuters) - The U.S. Food and Drug Administration has notified Genzyme Corp that it will re-inspect a key manufacturing plant because the biotechnology company did not take sufficient ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Genzyme's woes following the shutdown of its Allston ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results